1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with orsellinic acid in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (orsellinic acid) | Trials (orsellinic acid) | Recent Studies (post-2010) (orsellinic acid) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 57 | 0 | 39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnason, JT; Bazan, NG; Bennett, SA; Haddad, PS; Harris, CS; Hou, ST; Lee, H; Mo, F; Ryan, SD | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and orsellinic acid
| Article | Year |
|---|---|
Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.
Topics: Animals; Apoptosis; Benzoates; Caspase Inhibitors; Cells, Cultured; Crosses, Genetic; Enzyme Inhibitors; Gene Transfer Techniques; Mice; Mice, Knockout; Neurons; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Resorcinols; Signal Transduction | 2007 |